BioCardia, Inc. - Common Stock (BCDA)

BioCardia (BCDA) Q1 2026 Earnings Transcript

BioCardia (BCDA) Q3 2025 Earnings Call Transcript

BioCardia reports Q3 2025 results with no revenue and a wider-than-expected loss. The clinical-stage biotech continues advancing its cell therapy pipeline for heart failure.

On Tuesday, there are stocks with unusual volume. Let's take a look.

Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.

In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down.